Actinium Pharmaceuticals, Inc. - Director's Dealing 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Actinium Pharmaceuticals, Inc. (ATNM)
CIK: 0001388320
Period of Report: 2016-04-22

Reporting Person: Memorial Sloan-Kettering Cancer Center (10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-22	Common Stock	S	3041	$2.06	Disposed	5502849	Direct
2016-04-22	Common Stock	S	19759	$2.07	Disposed	5483090	Direct
2016-04-22	Common Stock	S	100	$2.0725	Disposed	5482990	Direct
2016-04-22	Common Stock	S	1000	$2.075	Disposed	5481990	Direct
2016-04-22	Common Stock	S	3692	$2.08	Disposed	5478298	Direct
2016-04-22	Common Stock	S	100	$2.09	Disposed	5478198	Direct
2016-04-25	Common Stock	S	1800	$2.00	Disposed	5476398	Direct
2016-04-25	Common Stock	S	200	$2.0025	Disposed	5476198	Direct
2016-04-25	Common Stock	S	500	$2.005	Disposed	5475698	Direct
2016-04-25	Common Stock	S	7600	$2.01	Disposed	5468098	Direct
2016-04-25	Common Stock	S	400	$2.0125	Disposed	5467698	Direct
2016-04-25	Common Stock	S	1200	$2.015	Disposed	5466498	Direct
2016-04-25	Common Stock	S	877	$2.02	Disposed	5465621	Direct
2016-04-25	Common Stock	S	3400	$2.05	Disposed	5462221	Direct
2016-04-25	Common Stock	S	2408	$2.06	Disposed	5459813	Direct
2016-04-26	Common Stock	S	4000	$1.95	Disposed	5455813	Direct
2016-04-26	Common Stock	S	2500	$1.97	Disposed	5453313	Direct